News

Neuroscientists Gary Lewin and James Poulet at the Max Delbrück Center for Molecular Medicine have won highly coveted and competitive ERC Advanced Grants to study pain and the neural mechanisms that underlie temperature perception.

On January 29th, the European Animal Research Association (EARA) and Charité –Universitätsmedizin Berlin, in collaboration with the Max Delbrück Center and Freie Universität Berlin, invite those working in the life science sector to discuss the need for greater transparency in animal research.

A tumor often arises when cancer genes multiply. In this process, additional genes act as hitchhikers, potentially creating previously unknown vulnerabilities that open the door to new therapeutic approaches. This finding is reported by a team led by ECRC-scientists Anton Henssen and Jan Dörr in "Cancer Discovery."

From 2024, the Federal Government and the State of Berlin will fund the establishment of the National Center for Tumor Diseases (NCT) Berlin. The new site is a cooperation between DKFZ and Charité, BIH, and Max Delbrück Center aimed at closely integrating clinical and translational cancer research.

Simon Haas has been awarded the Lisec-Artz Prize, endowed with €10,000, for his single-cell analysis of communication between stem and immune cells in blood cancer. The University of Bonn Foundation established this prize to honor outstanding early-career cancer researchers.

Sofia Forslund, Friedemann Paul, and Nikolaus Rajewsky are among the Highly Cited Researchers 2023. Each year the company Clarivate compiles a "Who's Who" list of highly influential researchers.

Swapping just a single amino acid can play a decisive role in transforming healthy B cells into cancer cells. An international team led by ECRC researcher Stephan Mathas describes in “Nature Communications” how a point mutation in the transcription factor IRF4 profoundly alters gene regulation.

When the PRDM16 gene mutates, heart muscle cells undergo changes in their metabolism. This increases the risk of congenital heart failure in women more than men, as a ECRC research team led by Sabine Klaassen and Jirko Kühnisch reports in “Cardiovascular Research.”

After spending many years researching together, a group of scientists has founded CARTemis Therapeutics, a spin-off from the Max Delbrück Center. Uta Höpken, Armin Rehm, Anthea Wirges, and Mario Bunse want to use novel CAR T-cell therapies to help patients with cancers that are currently untreatable.

Cryo-electron microscopy allows structural biologists to look at the most minute building blocks of life. We celebrated the opening of the joint Core Facility and the corresponding research building of Charité – Universitätsmedizin Berlin and the Max Delbrück Center with a symposium.